Hepatocyte Growth Factor And Met In Tumour Invasionmetastasis From Mechanisms To Cancer Prevention

Kunio Matsumoto and Toshikazu Nakamura

Key words: c-met, hepatocyte growth factor, HGF-antagonist, scatter factor, tumour angiogenesis, tumour-stromal interaction

Abstract: Hepatocyte growth factor (HGF), a ligand for c-met proto-oncogene product of receptor tyrosine kinase, exhibits powerful motogenic and angiogenic activities. The utilization of the HGF-Met system in cancer cells confers invasive and metastatic potentials. HGF potently enhances dissociation of cells, cell-matrix interaction, extracellular matrix breakdown, invasion, and angiogenesis, all critical events in the metastatic cascade. Tumour-stromal interaction mediated by HGF, aberrant expression of Met, autocrine or mutational activation of Met are tightly associated with carcinogenesis and malignant progression in a wide variety of tumours. Notably, NK4, the four kringle-antagonist for HGF-Met signaling inhibited tumour invasion and metastasis. The possibility has arisen that an HGF-antagonist can serve as a new therapeutic strategy for treatment of cancer patients. In normal tissues, HGF supports dynamic tissue remodeling for regeneration and the clinical application of HGF for treatment of organ failure/fibrosis will be initiated within a few years. These "two-pronged approaches" regarding HGF will lead to tissue repair and perhaps even the prevention of cancer.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment